BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32754366)

  • 1. Fulminant presentation of a SMARCB1-deficient, anterior cranial fossa tumor in adult.
    Levitan I; Fichman S; Laviv Y
    Surg Neurol Int; 2020; 11():195. PubMed ID: 32754366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical teratoid rhabdoid tumor involving the nasal cavities and anterior skull base.
    Barresi V; Branca G; Raso A; Mascelli S; Caffo M; Tuccari G
    Neuropathology; 2016 Jun; 36(3):283-289. PubMed ID: 26567940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
    Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
    Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Appearance of
    Shatzkes DR; Ginsberg LE; Wong M; Aiken AH; Branstetter BF; Michel MA; Aygun N
    AJNR Am J Neuroradiol; 2016 Oct; 37(10):1925-1929. PubMed ID: 27390322
    [No Abstract]   [Full Text] [Related]  

  • 9. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
    Agaimy A
    Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary intracerebral INI1-deficient rhabdoid tumor with CD34 immunopositivity in a young adult.
    Bodi I; Giamouriadis A; Sibtain N; Laxton R; King A; Vergani F
    Surg Neurol Int; 2018; 9():45. PubMed ID: 29541486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience.
    Bell D; Hanna EY; Agaimy A; Weissferdt A
    Virchows Arch; 2015 Dec; 467(6):649-656. PubMed ID: 26407663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
    Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
    Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.
    Agaimy A; Koch M; Lell M; Semrau S; Dudek W; Wachter DL; Knöll A; Iro H; Haller F; Hartmann A
    Am J Surg Pathol; 2014 Sep; 38(9):1274-81. PubMed ID: 24832165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
    Trieu V; Aulet RM; Ciolino A; Rimash T
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
    Ayyanar P; Mishra P; Preetam C; Adhya AK
    Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SMARCB1 (INI1)-deficient sinonasal carcinoma: a clinicopathological analysis of six cases].
    Tang SJ; Zhai CW; Yuan CC; Zhang JH; Wang SY
    Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):47-51. PubMed ID: 31914534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.